GlobeNewswire by notified

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2023 Annual General Meeting


12 JANUARY 2023 at 10.15 EET

Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2023 Annual General Meeting

The Nomination Committee of Orion Corporation has on 12 January 2023 given to the company’s Board of Directors its recommendation on the proposal to the Annual General Meeting of 2023 concerning the composition of the Board of Directors to be elected by the meeting. The Committee recommends that the following proposal be presented to the AGM of 2023:

Recommendation on the number of members of the Board of Directors and its composition

The number of Board members would be eight.

The present members of the Board, Kari Jussi Aho, Maziar Mike Doustdar, Ari Lehtoranta, Veli-Matti Mattila, Hilpi Rautelin, Eija Ronkainen, Mikael Silvennoinen and Karen Lykke Sørensen would be re-elected for the next term of office.

Mikael Silvennoinen would be re-elected as the Chairman of the Board.

Recommendation on remuneration to be paid to members of the Board of Directors

In addition, the Nomination Committee announces as its recommendation that the following remunerations would be paid to the Board of Directors:

As an annual fee, the Chairman would receive EUR 100,000, the Vice Chairman would receive EUR 61,000 and the other members would receive EUR 50,000 each. However, if a member of the board acts as the Chairman of the Audit Committee or the R&D Committee, her/his annual fee would be EUR 61,000.

In addition, as a fee for each meeting attended, the Chairman would receive EUR 1,200, the Vice Chairman would receive EUR 900 and the other members would receive EUR 600 each. The travel expenses of the Board members would be paid in accordance with the previously adopted practice. The aforementioned meeting attendance fees would also be paid to the Chairmen and to the members of the committees established by the Board. The meeting attendance fees of Board members permanently resident outside Finland would be doubled if the meeting was held outside the country of residence of such a member and the person attended the meeting at the place of the meeting.

Of the above-mentioned annual fees, 60 percent would be paid in cash and 40 percent in Orion Corporation B shares, which would be acquired for the members over the period 28 April–5 May 2023 from the stock exchange in amounts corresponding to EUR 40,000 for the Chairman, EUR 24,400 for the Vice Chairman and for the board members acting as the Chairmen of the Audit Committee and the R&D Committee and EUR 20,000 for each of the other members. The part of the annual fee that is to be paid in cash corresponds to the approximate sum necessary for the payment of the income taxes on the fees and would be paid no later than 31 May 2023. The annual fees shall encompass the full term of office of the Board of Directors.

In addition, the company would pay the transfer tax related to the part of the annual fee of the Board of Directors paid in shares.

Potential statutory social security and pension costs incurring to Board members having permanent residence outside Finland would be borne by Orion Corporation as required by the applicable national legislation.

Board members would be required to retain ownership of the Orion Corporation B shares paid as fees for a period of two years from the date of payment of the fees. However, if the person's membership of the Board of Directors of the company were to end before the expiry of the restriction on transfer, the restriction on transfer would expire at the end of the membership of the Board of Directors.

The Nomination Committee has not given its recommendation for the remunerations to the Board of Directors, but the matter will be proposed by a shareholder at the AGM.

The Nomination Committee notes that the annual fees are recommended to be increased approximately by 11 percent. Meeting fees are the same as those decided in 2022.

The members of the Nomination Committee belonging to the Board of Directors did not participate in the consideration or decision-making of the recommendation on the remuneration of the Board of Directors.

The Nomination Committee has consisted of the following members: Heikki Westerlund, Chairman, Annika Ekman, Petteri Karttunen, Timo Maasilta, Hilpi Rautelin and Mikael Silvennoinen.

Orion Corporation

Liisa Hurme

President and CEO
Olli Huotari

SVP, Corporate Functions

Contact person:
Heikki Westerlund, Chairman of the Nomination Committee
Tel. +358 50 559 6580

Orion Corporation
Orionintie 1A, FI-02200 Espoo, Finland

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 amounted to EUR 1,041 million and the company had about 3,350 employees at the end of the year. Orion’s A and B shares are listed on Nasdaq Helsinki.

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Bogdan Viher of HYCU® Receives Prominent 2023 CRN Channel Chief Recognition6.2.2023 18:00:00 CET | Press release

Channel Industry Veteran Driving Value of Purpose-Built Data Protection and DR Solutions for Multi-Cloud and SaaS Environments with Partners Highlight Industry Recognition Boston, Massachusetts, Feb. 06, 2023 (GLOBE NEWSWIRE) -- HYCU, Inc., the world’s fastest-growing multi-cloud data protection as a service company, announced today that CRN, a brand of The Channel Company, has named Bogdan Viher, Head of Global Channels, at HYCU, Inc. to its 2023 Channel Chiefs list. CRN’s annual Channel Chiefs project identifies top IT channel vendor executives who continually demonstrate expertise, influence, and innovation in channel leadership. A panel of CRN editors selected the honorees for their channel dedication, industry stature, and accomplishments as channel advocates. The 2023 Channel Chiefs are influential leaders who continue to shape the IT channel with innovative strategies, programs, and partnerships. “To be a visionary, working with like-minded and forward-thinking partners, require

Mendus AB: Mendus tillkännager begäran från Negma Group om konvertering av konvertibla skuldebrev6.2.2023 18:00:00 CET | Pressemelding

Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier mot tumöråterfall, tillkännager idag att Negma Group (”Negma”) genom meddelande till Mendus har begärt konvertering av konvertibla skuldebrev som utfärdats till Negma i enlighet med det finansieringsavtal som Mendus tillkännagivit genom pressmeddelanden den 26 augusti och 26 oktober 2022. Negma har begärt konvertering av 22 konvertibla skuldebrev som emitterades den 3 januari 2023, motsvarande 550 000 kronor av det konvertibla lånet som uppgår till totalt 13 400 000 kronor, till 249 999 aktier. Efter registrering hos Bolagsverket kommer Mendus totala aktiekapital att uppgå till 9 988 627,45 kronor och det totala antalet aktier och röster kommer att uppgå till 199 772 549. Konverteringspriset per aktie är 2,20 kronor, motsvarande 92% av det lägsta dagliga volymvägda genomsnittliga aktiekursen (VWAP) under de 10 på varandra följande handelsdagarna före konverteringsbegäran från Negma. För ytterligare

Ilkka Oyj – Acquisition of own shares on 6 February 20236.2.2023 18:00:00 CET | Press release

ILKKA OYJ, STOCK EXCHANGE RELEASE, 6 February 2023 at 19:00 EET IlkkaOyj – Acquisition of own shares on 6 February 2023 At Nasdaq Helsinki Ltd: Date6 February 2023Exchange transactionBuyShare trading codeILKKA2Amount, shares 980Average price/share, EUR4.0693Total cost, EUR3,987.91 The company holds a total of 47,186 of its own shares (ILKKA2) including the shares acquired on 6 February 2023. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 Attachment Ilkka buyback 6.2.2023

Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group6.2.2023 18:00:00 CET | Press release

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022. Negma has requested conversion of 22 convertible bonds issued on 3 January 2023, corresponding to SEK 550,000 of the convertible loan amounting to a total of SEK 13,400,000, into 249,999 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 9,988,627,45 and the total number of shares and votes will amount to 199,772,549. The conversion price per share is SEK 2.20, equivalent to 92% of the lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma. For further

Innofactor Plc: Share Repurchase 6.2.20236.2.2023 17:30:00 CET | Press release

Innofactor Plc Announcement 6.2.2023Innofactor Plc: Share Repurchase 6.2.2023In the Helsinki Stock ExchangeTrade date 6.2.2023Bourse trade BuyShare IFA1VAmount 5,950SharesAverage price/ share 1.1700EURTotal cost 6,961.50EURInnofactor Plc now holds a total of 1 377 186 sharesincluding the shares repurchased on 6.2.2023On behalf of Innofactor PlcNordea Bank OyjJanne Sarvikivi Sami HuttunenAdditional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 Attachment Innofactor_6.2_trades